StockData
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) bonds

JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30122% above fair value
$240.71+0.94 (+0.39%)

Close on Nov 17, 2026Market cap $15.63BP/E 78.4Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$5.57B
$1.02B due within a year
Net debt
$3.53B
After $2.04B of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Jazz Pharmaceuticals's 10-Q for the period ended Jun 30, 2026

IssueCouponMaturesAmount issuedCarrying value
2026 Notes
Convertible at $156 a share
2.00%2026$1.00B$0
2030 Notes
Convertible at $153 a share
3.13%2030$1.00B$1.00B
2021 Credit Agreement, Euro Term Loan4.43%–––
Secured Notes–––$1.49B
Tranche B 2 Dollar Term Loan5.97%–$289.60M–
Tranche B-1 Dollar Term Loan––$201.90M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeAvailable
2021 Credit Agreement, Revolving Credit Facility$885.00M$885.00M

See a number that looks wrong?